Alvarez-Calderon, Francesca

Tyrosine kinase inhibition in leukemia induces an altered metabolic state sensitive to mitochondrial perturbations. [electronic resource] - Clinical cancer research : an official journal of the American Association for Cancer Research Mar 2015 - 1360-72 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1557-3265

10.1158/1078-0432.CCR-14-2146 doi


Animals
Antineoplastic Combined Chemotherapy Protocols--pharmacology
Apoptosis--drug effects
Cell Line, Tumor
Dihydrolipoyllysine-Residue Acetyltransferase--genetics
Disease Models, Animal
Female
Fusion Proteins, bcr-abl--metabolism
Humans
Imatinib Mesylate--pharmacology
Ketone Oxidoreductases--metabolism
Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy
Membrane Potential, Mitochondrial--drug effects
Mice
Mice, Inbred C57BL
Mice, Inbred NOD
Mice, Knockout
Mitochondria--metabolism
Mitochondrial Proteins--genetics
Mitochondrial Proton-Translocating ATPases--antagonists & inhibitors
Oligomycins--pharmacology
Protein Kinase Inhibitors--pharmacology
Protein-Tyrosine Kinases--antagonists & inhibitors
RNA Interference
RNA, Small Interfering
Superoxides--metabolism
fms-Like Tyrosine Kinase 3--genetics